Skip to main content
MedPathMedPath Home
Clinical Trials/NCT04181437
NCT04181437
Completed
Phase 1

A Phase I Clinical Trial to Evaluate the Pharmacokinetic Interaction and Safety Between NVP-1203-R1 and NVP-1203-R2 in Healthy Adult Subjects

NVP Healthcare1 site in 1 country40 target enrollmentMay 1, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealthy
InterventionsNVP-1203-R1 and NVP-1203-R2NVP-1203-R1NVP-1203-R2
DrugsNVP-1203-R1 and NVP-1203-R2NVP-1203-R1NVP-1203-R2

Overview

Phase
Phase 1
Intervention
NVP-1203-R1 and NVP-1203-R2
Conditions
Healthy
Sponsor
NVP Healthcare
Enrollment
40
Locations
1
Primary Endpoint
Pharmacokinetic interaction
Status
Completed
Last Updated
5 years ago
OverviewInvestigatorsEligibility CriteriaArms & InterventionsOutcomesSitesSimilar Trials

Overview

Brief Summary

The purpose of this study is to compare the pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Detailed Description

pharmacokinetics and safety between NVP-1203-R1 and NVP-1203-R2

Registry
clinicaltrials.gov
Start Date
May 1, 2020
End Date
May 29, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
NVP Healthcare
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •healthy adult subjects who signed informed consent

Exclusion Criteria

  • •Subjects has a history of allergy reaction of study drug ingredient
  • •Subjects participated in another clinical trial within 6 months prior to administration of the study drug
  • •Inadequate subject for the clinical trial by the investigator's decision

Arms & Interventions

NVP-1203-R1 and NVP-1203-R2

Drug: NVP-1203-R1 1 tablet and NVP-1203-R2 1 tablet co-administration(oral dosing)

Intervention: NVP-1203-R1 and NVP-1203-R2

NVP-1203-R1

Drug: NVP-1203-R1 1 tablet, oral dosing

Intervention: NVP-1203-R1

NVP-1203-R2

Drug: NVP-1203-R2 1 tablet, oral dosing

Intervention: NVP-1203-R2

Outcomes

Primary Outcomes

Pharmacokinetic interaction

Time Frame: 0hours - 24hours

Area under the curve (AUC)

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of NVP-1402Healthy
NCT02897726NVP Healthcare38
Completed
Phase 1
Evaluation of Pharmacokinetic and Safety of NVP-1705 and NVP-1705-R in Healthy SubjectsHealthy Subjects
NCT05141110NVP Healthcare50
Completed
Phase 1
Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy SubjectsHealthy Subjects
NCT05023031NVP Healthcare53
Completed
Phase 1
To Evaluate the Safety and the Pharmacokinetics of NVP-2203Healthy Volunteers
NCT05725252NVP Healthcare50
Completed
Phase 1
NVP-1805 Compared to Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Adult Volunteers (BE)Healthy Volunteers
NCT05354713NVP Healthcare58